The re-emergence of pertussis: implications for diagnosis and surveillance
Vitali SintchenkoA Centre for Infectious Diseases and Microbiology-Public Health, Sydney West Area Health Service, Western Clinical School, University of Sydney.
NSW Public Health Bulletin 19(8) 143-145 https://doi.org/10.1071/NB07005
Published: 20 October 2008
Abstract
Pertussis, or whooping cough, a highly contagious disease caused by Bordetella pertussis, is making a comeback globally and nationally in spite of reasonable vaccination coverage. This paper provides an update on laboratory testing methods that assist the confirmation of clinical disease and investigation of outbreaks. Laboratory confirmation of the diagnosis by polymerase chain reaction or serology should be attempted, especially when atypical pertussis is suspected clinically. Genetic and antigenic variations in virulence factors of strains circulating in the population should also be monitored.
Acknowledgment
The author thanks Professor Lyn Gilbert for her critical appraisal of the manuscript.
[1] Fry NK, Tzivra O, Li YT, McNiff A, Doshi NP, Maple AC, et al. Laboratory diagnosis of pertussis infections: the role of PCR and serology. J Med Microbiol 2004; 53 519–25.
| Crossref | GoogleScholarGoogle Scholar | PubMed | CAS |
[2] Riffelmann M, von Konig CHW, Caro V, Guios N. Nucleic acid amplification tests for diagnosis of Bordetella infections. J Clin Microbiol 2005; 43 4925–9.
| Crossref | GoogleScholarGoogle Scholar | PubMed | CAS |
[3] Cherry JD, Grimprel E, Guiso N, Heininger U, Mertsola J. Defining pertussis epidemiology: Clinical, microbiology and serological perspectives. Pediatr Infect Dis 2005; 25 S25–34.
[4] Tozzi AE, Celentano LP, Atti MLC, Salmaso S. Diagnosis and management of pertussis. Can Med Assoc J 2005; 172 509–15.
| Crossref | GoogleScholarGoogle Scholar |
[5] Wright SW. Pertussis infection in adults. South Med J 1998; 91 702–8.
| PubMed | CAS |
[6] Elomaa A, Advani A, Donnelly D, Antila M, Mertsola J, He Q, et al. Population dynamics of Bordetella pertussis in Finland and Sweden, neighbouring countries with different vaccination histories. Vaccine 2007; 25 918–26.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[7] Van Amersfoorth SCM, Schouls LM, van der Heide HGJ, Advani A, Hallander HO, Bondeson K, et al. Analysis of Bordetella pertussis populations in European countries with different vaccination policies. J Clin Microbiol 2005; 43 2837–43.
| Crossref | GoogleScholarGoogle Scholar | PubMed | CAS |
[8] Fingermann M, Fernandez J, Sisti F, Rodriguez ME, Gatti B, Bottero D, et al. Differences in circulating Bordetella pertussis population in Argentina from the strain used in vaccine production. Vaccine 2006; 24 3513–21.
| Crossref | GoogleScholarGoogle Scholar | PubMed | CAS |
[9] Poynten M, McIntyre PB, Mooi FR, Heuvelman KJ, Gilbert GL. Temporal trends in circulating Bordetella pertussis strains in Australia. Epidemiol Infect 2004; 132 185–93.
| Crossref | GoogleScholarGoogle Scholar | PubMed | CAS |
[10] Byrne S, Slack AT. Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999–2003. BMC Infect Dis 2006; 6 53.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
